Sách Bad Blood pdf ebook review doc epub word wattpad prc mobi audio mp3 sách nói đọc online Tác giả: John Carreyrou.
👉 Link Sách: https://bit.ly/3ywAklZ
1. Review sách Bad Blood
Sách Bad Blood ebook review pdf dowload word audio mp3 Tác giả: John Carreyrou trong danh mục Sách Ngoại văn ngoại ngữ đang sale off % còn 204.300 ₫, Đứng thứ 10 trong Top 1000 Social Sciences bán chạy tháng này đã được bán ra hơn 133 cuốn ngay sau khi lên kệ, cùng với 18 nhận xét, đánh giá từ độc giả.
2. Thông tin sách Bad Blood
Sách Bad Blood Tác giả: John Carreyrou, Công ty phát hành Random House US ISBN-13 9781524711481.
| Công ty phát hành | Random House US |
| ISBN-13 | 9781524711481 |
3. Mô tả sách Bad Blood
***A National Bestseller*** One of the Best Books of 2018: NPR – New York Times Book Review, Inc. – TIME – Wall Street Journal – Washington Post – The McKinsey Business Book of the Year “The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.” –Bill Gates The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work. A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. .